Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.24B 12.92M 11.07M 10.36M 9.48M 17.8M 18.03M 122M 47.73M 621M 48.53M 47.48M 2.05B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.65B 17.22M 14.75M 13.8M 12.63M 23.71M 24.03M 163M 63.59M 828M 64.66M 63.26M 2.74B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day+0.45%
1 week-6.67%
Current month-6.28%
1 month-5.00%
3 months-10.54%
6 months+11.44%
Current year-16.64%
1 week 21.5
Extreme 21.5
24.3
1 month 21.5
Extreme 21.5
25.5
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
47.88
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 04/05/2017
Director of Finance/CFO - 20/05/2021
Compliance Officer - 25/03/2026
Director TitleAgeSince
Chairman 56 04/05/2017
Director/Board Member 54 -
Director/Board Member 44 04/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%-6.67%-53.28%-76.30% 12.92M
+2.40%-1.16%+21.66%+101.69% 100B
+0.46%-2.41%+51.42%+163.99% 53.38B
0.00%-2.68%+1.75%+279.08% 23.91B
-2.82%-2.41%-15.68%-14.61% 8.09B
-6.08%-5.45%-38.53%-23.47% 7.33B
+0.42%-0.30%-15.40%-23.27% 6.63B
+0.88%-3.48%+4.43%+19.93% 6.34B
-0.91%+1.05%-4.38%+17.58% 5.09B
-2.58%-2.96%-9.58%-4.65% 3.64B
Average -0.78%-2.35%-5.76%+44.00% 21.46B
Weighted average by Cap. +0.89%-1.77%+20.57%+118.21%

Financials

2025 2026
Net sales 2.93B 30.58M 26.19M 24.51M 22.43M 42.1M 42.66M 290M 113M 1.47B 115M 112M 4.86B 2.7B 28.24M 24.19M 22.63M 20.72M 38.88M 39.39M 267M 104M 1.36B 106M 104M 4.49B
Net income 251M 2.62M 2.24M 2.1M 1.92M 3.61M 3.66M 24.81M 9.68M 126M 9.84M 9.62M 417M 14.17M 148K 127K 119K 109K 204K 207K 1.4M 547K 7.12M 556K 544K 23.54M
Net Debt 127M 1.33M 1.14M 1.07M 976K 1.83M 1.85M 12.59M 4.91M 63.91M 4.99M 4.88M 211M 411M 4.3M 3.68M 3.44M 3.15M 5.92M 5.99M 40.68M 15.87M 206M 16.13M 15.78M 683M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
21/08/26 ₹22.40 +0.45% 50,714
20/08/26 ₹22.30 -6.26% 139,295
19/08/26 ₹23.79 +0.30% 30,405
18/08/26 ₹23.72 -2.02% 27,297
17/08/26 ₹24.21 +0.88% 27,550
  1. Stock Market
  2. Stocks
  3. BALAXI Stock